| 000 | 01463 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250511183732.0 | ||
| 264 | 0 | _c19921211 | |
| 008 | 199212s 0 0 eng d | ||
| 022 | _a0390-6078 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aCatani, L | |
| 245 | 0 | 0 |
_aIn vitro inhibition of interferon alpha-2a antiproliferative activity by antibodies developed during treatment for essential thrombocythaemia. _h[electronic resource] |
| 260 |
_bHaematologica _c |
||
| 300 |
_a318-21 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aCell Division _xdrug effects |
| 650 | 0 | 4 | _aCells, Cultured |
| 650 | 0 | 4 | _aColony-Forming Units Assay |
| 650 | 0 | 4 | _aDrug Tolerance |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunologic Factors _xtherapeutic use |
| 650 | 0 | 4 | _aInterferon alpha-2 |
| 650 | 0 | 4 |
_aInterferon-alpha _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aIsoantibodies _xblood |
| 650 | 0 | 4 |
_aMegakaryocytes _xdrug effects |
| 650 | 0 | 4 | _aNeutralization Tests |
| 650 | 0 | 4 | _aRecombinant Proteins |
| 650 | 0 | 4 |
_aThrombocythemia, Essential _ximmunology |
| 700 | 1 | _aGugliotta, L | |
| 700 | 1 | _aZauli, G | |
| 700 | 1 | _aBagnara, G P | |
| 700 | 1 | _aAntonelli, G | |
| 700 | 1 | _aBelmonte, M M | |
| 700 | 1 | _aVianelli, N | |
| 700 | 1 | _aBonsi, L | |
| 700 | 1 | _aBrunelli, M A | |
| 700 | 1 | _aTura, S | |
| 773 | 0 |
_tHaematologica _gvol. 77 _gno. 4 _gp. 318-21 |
|
| 999 |
_c1433934 _d1433934 |
||